Non-Small Cell Lung Cancer Therapeutics Market Outlook 2036
The global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market is set for remarkable growth over the next decade, driven by rising disease prevalence and rapid innovations in treatment modalities. NSCLC, which accounts for approximately 85% of all lung cancer cases, remains one of the leading causes of cancer-related mortality worldwide. With advancements in precision medicine, immunotherapy, and targeted therapies, treatment paradigms are evolving to improve survival rates and patient outcomes.